Lead sponsor
Luye Pharma Group Ltd.
6 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
6
Trials led
4
Ongoing
248
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
6
Trials by status
Not yet recruiting
2
Recruiting
1
Active, not recruiting
1
Completed
1
Unknown
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy SubjectsAge 18-45Ph 1Completed66
A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020Healthy volunteersPh 1Recruiting40
A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017Age 18-45Ph 1Not yet recruiting40